|
ANKFY1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.200280E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.820400E-02 |
| Normal-vs-Stage2 |
4.159400E-01 |
| Normal-vs-Stage3 |
8.928800E-01 |
| Normal-vs-Stage4 |
2.798400E-02 |
| Stage1-vs-Stage2 |
8.528600E-01 |
| Stage1-vs-Stage3 |
2.401800E-01 |
| Stage1-vs-Stage4 |
3.283000E-03 |
| Stage2-vs-Stage3 |
4.662600E-01 |
| Stage2-vs-Stage4 |
4.950100E-02 |
| Stage3-vs-Stage4 |
1.769760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.770220E-02 |
| Normal-vs-AfricanAmerican |
3.250600E-01 |
| Normal-vs-Asian |
7.212800E-01 |
| Caucasian-vs-AfricanAmerican |
4.936000E-01 |
| Caucasian-vs-Asian |
4.462200E-01 |
| AfricanAmerican-vs-Asian |
5.341200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.176300E-02 |
| Normal-vs-Female |
1.988160E-02 |
| Male-vs-Female |
2.083200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.928200E-01 |
| Normal-vs-Extreme_Weight |
6.831000E-01 |
| Normal-vs-Obese |
6.422300E-02 |
| Normal-vs-Extreme_Obese |
3.383200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.932400E-01 |
| Normal_Weight-vs-Obese |
1.585400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.733600E-01 |
| Extreme_Weight-vs-Obese |
2.455000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.405200E-01 |
| Obese-vs-Extreme_Obese |
6.613400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.248200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.823130E-03 |
| Normal-vs-Age(61-80Yrs) |
2.692400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.000600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.102800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.952400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.953600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.268100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.169700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.470960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.755800E-04 |
| Normal-VS-Type2 PRCC |
7.431800E-01 |
| Normal-VS-KIRP CIMP |
2.202600E-01 |
| Normal-VS-Unclassified PRCC |
2.206500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.602300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.301600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.462800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.902800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.686380E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.376200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.698400E-01 |
| Normal-vs-N1 |
9.910200E-01 |
| Normal-vs-N2 |
9.97779999999393E-05 |
| N0-vs-N1 |
6.410400E-01 |
| N0-vs-N2 |
1.128390E-01 |
| N1-vs-N2 |
8.817800E-02 |
|
|
